Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection.
Shein AMS, Wannigama DL, Hurst C, Monk PN, Amarasiri M, Badavath VN, Phattharapornjaroen P, Ditcham WGF, Ounjai P, Saethang T, Chantaravisoot N, Thuptimdang W, Luk-In S, Nilgate S, Rirerm U, Tanasatitchai C, Kueakulpattana N, Laowansiri M, Liao T, Kupwiwat R, Rojanathanes R, Ngamwongsatit N, Thammahong A, Ishikawa H, Pletzer D, Leelahavanichkul A, Ragupathi NKD, Wapeesittipan P, Ali Hosseini Rad SM, Kanjanabuch T, Storer RJ, Miyanaga K, Cui L, Hamamoto H, Higgins PG, Kicic A, Chatsuwan T, Hongsing P, Abe S.
Shein AMS, et al. Among authors: hurst c.
Biomed Pharmacother. 2023 Oct 28;168:115793. doi: 10.1016/j.biopha.2023.115793. Online ahead of print.
Biomed Pharmacother. 2023.
PMID: 39491417
Free article.